Cargando…

Animal models of bone metastatic prostate cancer

Metastatic disease is a main cause of mortality in prostate cancer and remains to be incurable despite emerging new treatment agents. Development of novel treatment agents are confined within the boundaries of our knowledge of bone metastatic prostate cancer. Exploration into the underlying mechanis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tae, Jong Hyun, Chang, In Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172043/ https://www.ncbi.nlm.nih.gov/pubmed/37341002 http://dx.doi.org/10.4111/icu.20230026

Ejemplares similares

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
por: El-Amm, Joelle, et al.
Publicado: (2016)

Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art
por: Mollica, Veronica, et al.
Publicado: (2021)

Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned
por: Thomas, Christian, et al.
Publicado: (2016)

Characterization of a rat model of metastatic prostate cancer bone pain
por: De Ciantis, Paolo Donato, et al.
Publicado: (2010)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancer
por: Inaba, Koji, et al.
Publicado: (2021)

Neutrophils are mediators of metastatic prostate cancer progression in bone
por: Costanzo-Garvey, Diane L., et al.
Publicado: (2020)

Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms
por: Ardura, Juan A., et al.
Publicado: (2020)

Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
por: Lee, Sanghee, et al.
Publicado: (2022)

2020 Korean guidelines for the management of metastatic prostate cancer
por: Kim, In-Ho, et al.
Publicado: (2021)

Immunotherapy in metastatic prostate cancer
por: Slovin, Susan F.
Publicado: (2016)

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
por: Cook, Leah M., et al.
Publicado: (2016)

Systemic treatment for metastatic prostate cancer
por: Gravis, Gwenaelle
Publicado: (2019)

Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancer
por: Gupta, Nisha, et al.
Publicado: (2016)

Radioisotopes in management of metastatic prostate cancer
por: Raval, Amar, et al.
Publicado: (2016)

Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
por: Paiva, Ana E., et al.
Publicado: (2017)

Liver uptake on bone scan for prostate cancer metastatic workup
por: Mukendi, Alain Mwamba
Publicado: (2019)

Use of Animal Models in Understanding Cancer-induced Bone Pain
por: Slosky, Lauren M, et al.
Publicado: (2015)

Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials
por: Lee, Yong Seong, et al.
Publicado: (2023)

COOPERATION AMONG HETEROGENEOUS PROSTATE CANCER CELLS IN THE BONE METASTATIC NICHE
por: Shahriari, Kristina, et al.
Publicado: (2016)

From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011)

Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
por: Miyoshi, Yasuhide, et al.
Publicado: (2015)

Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion()
por: Wang, Yugang, et al.
Publicado: (2020)

Bone marrow involvement in patients with metastatic castration sensitive prostate cancer
por: Shahait, Mohammed, et al.
Publicado: (2022)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

Metastatic prostate cancer remains incurable, why?
por: Dong, Liang, et al.
Publicado: (2019)

Human ex vivo 3D bone model recapitulates osteocyte response to metastatic prostate cancer
por: Choudhary, Saba, et al.
Publicado: (2018)

Animal models for bone tissue engineering and modelling disease
por: McGovern, Jacqui Anne, et al.
Publicado: (2018)

PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche
por: Godebu, Elana, et al.
Publicado: (2014)

STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs
por: Sharma, Aditya Prakash, et al.
Publicado: (2018)

The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
por: Kase, Adam M., et al.
Publicado: (2022)

Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
por: Johnson, Catherine S., et al.
Publicado: (2023)

Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer
por: Kumar, Shreya, et al.
Publicado: (2023)

Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma
por: Mathur, Pankaj, et al.
Publicado: (2017)

Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
por: Josefsson, Andreas, et al.
Publicado: (2018)

Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer
por: Gerdts, Ethan, et al.
Publicado: (2015)

Use of nanoparticles in animal models for prostate cancer treatment: a systematic review
por: Selzler, Michele, et al.
Publicado: (2023)

Animal models of vertical bone augmentation (Review)
por: Zhang, Zepeng, et al.
Publicado: (2021)

Animal Models of Bone Marrow Lesions in Osteoarthritis
por: Bowen, Andrew, et al.
Publicado: (2022)

Current Studies of Acupuncture in Cancer-Induced Bone Pain Animal Models
por: Ryu, Hee Kyoung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_52oif0qeha1s0glkhud8s14cde